Molecular mechanisms of melatonin's inhibitory actions on breast cancers. (Q38046127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Molecular mechanisms of melatonin's inhibitory actions on breast cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sara Proietti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Russel J Reiter

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

25 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

2139-2157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and its analogs in insomnia and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and reproduction revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin as a natural ally against oxidative stress: a physicochemical examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Extended exposure to dietary melatonin reduces tumor number and size in aged male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and cancer: current knowledge and its application to oral cavity tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and Associated Signaling Pathways that Control Normal Breast Epithelium and Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Principles of psychoneuroendocrinoimmunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin, sleep disturbance and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Circadian rhythms and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Light at night, chronodisruption, melatonin suppression, and cancer risk: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Effects of some low molecular weight sheep pineal fractions and melatonin on different tumors in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Therapeutic actions of melatonin in cancer: possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Dietary cadmium and risk of invasive postmenopausal breast cancer in the VITAL cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Two hundred years of cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Why the incidence of cancer is increasing: the role of 'light pollution'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Night shift work, light at night, and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Increased breast cancer risk among women who work predominantly at night

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin increases the survival time of animals with untreated mammary tumours: neuroendocrine stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and mammary cancer: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The role of pineal gland in breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Pineal melatonin inhibition of tumor promotion in theN-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Prooxidant states and tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The validity of melatonin as an oncostatic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Effects of melatonin on the cell cycle kinetics and "estrogen-rescue" of MCF-7 human breast cancer cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and vitamin D3 increase TGF-beta1 release and induce growth inhibition in breast cancer cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and mammary pathological growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Differential inhibition of fatty acid transport in tissue-isolated steroid receptor negative human breast cancer xenografts perfused in situ with isomers of conjugated linoleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Functional MT1 and MT2 melatonin receptors in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin membrane receptors in peripheral tissues: distribution and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Short-term exposure to melatonin differentially affects the functional sensitivity and trafficking of the hMT1 and hMT2 melatonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Endocrine Aspects of the Mammalian Pineal Gland:A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The Pineal and Its Hormones in the Control of Reproduction in Mammals*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Molecular pathways involved in seasonal body weight and reproductive responses governed by melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Molecular pharmacology, regulation and function of mammalian melatonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Role of pineal gland in aetiology and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and pregnancy in the human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and the ovary: physiological and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The pineal gland and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and sex hormone interrelationships--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Functional melatonin receptors in rat ovaries at various stages of the estrous cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin-estrogen interactions in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin decreases estrogen receptor expression in the medial preoptic area of inbred (LSH/SsLak) golden hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Involvement of the mt1 melatonin receptor in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

International Union of Pharmacology. LXVI. Orphan nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Minireview: nuclear receptor coactivators--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Combinatorial control of gene expression by nuclear receptors and coregulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Orphan nuclear receptor RZRbeta: cyclic AMP regulates expression in the pineal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Expression of membrane and nuclear melatonin receptors in mouse peripheral organs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Role of melatonin in the epigenetic regulation of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Epigenetic actions of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin stimulates calmodulin phosphorylation by protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Calmodulin is a selective modulator of estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

IQGAP1 and calmodulin modulate E-cadherin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Relationship between 1-chloro-2,4-dinitrobenzene-induced cytoskeletal perturbations and cellular glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Calmodulin mediates melatonin cytoskeletal effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin suppression of PC12 cell growth and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Diurnal changes in cyclic nucleotide response to pineal indoles in murine mammary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Sex steroid-producing enzymes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Prostaglandin E2 increases cyp19 expression in rat granulosa cells: implication of GATA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin inhibits prostaglandin E2- and sodium nitroprusside-induced ion secretion in rat distal colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin modulation of estrogen‐regulated proteins, growth factors, and proto‐oncogenes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Cyclin D1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cycli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Minireview: Cyclin D1: normal and abnormal functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

p21 in cancer: intricate networks and multiple activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The epigenetic regulation of mammalian telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Mechanisms of cancer inhibition by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin and cell death: differential actions on apoptosis in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin, a natural programmed cell death inducer in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin induces apoptosis in human neuroblastoma cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin provokes cell death in human B-lymphoma cells by mitochondrial-dependent apoptotic pathway activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin sensitizes Caki renal cancer cells to kahweol‐induced apoptosis through CHOP‐mediated up‐regulation of PUMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apoptotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

MDM2--master regulator of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Chemical, oncogene and growth factor inhibition gap junctional intercellular communication: an integrative hypothesis of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Matrix metalloproteinases in health and disease: regulation by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Cytoplasmic microtubules and their functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Tensegrity II. How structural networks influence cellular information processing networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Geometric control of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Metabolism and cell shape in cancer: a fractal analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Cell migration: Rho GTPases lead the way

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin induced cyclic modulation of vectorial water transport in kidney-derived MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin increases stress fibers and focal adhesions in MDCK cells: participation of Rho-associated kinase and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Calmodulin bound to stress fibers but not microtubules involves regulation of cell morphology and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin as a cytoskeletal modulator: implications for cell physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1161-8

Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro

21 January 2018

1 reference

12 December 2020

Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions

1 reference

12 December 2020

Melatonin and cardiovascular disease: myth or reality?

1 reference

12 December 2020

Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity

1 reference

12 December 2020

Breast cancer therapy based on melatonin.

1 reference

12 December 2020

Scientific basis for the potential use of melatonin in bone diseases: osteoporosis and adolescent idiopathic scoliosis

1 reference

12 December 2020

Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism

1 reference

12 December 2020

Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene

1 reference

12 December 2020

Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.

1 reference

12 December 2020

Cross talk between melatonin and TGFbeta1 in human benign prostate epithelial cells

1 reference

12 December 2020

Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration

1 reference

12 December 2020

Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro

1 reference

12 December 2020

Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors

1 reference

12 December 2020

Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation

1 reference

12 December 2020

Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines

1 reference

12 December 2020

Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells

1 reference

12 December 2020

Nuclear melatonin receptors

1 reference

12 December 2020

Urinary melatonin levels in human breast cancer patients

1 reference

12 December 2020

Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?.

1 reference

12 December 2020

Melatonin blocks the activation of estrogen receptor for DNA binding

1 reference

12 December 2020

Clinical Results with the Pineal Hormone Melatonin in Advanced Cancer Resistant to Standard Antitumor Therapies

1 reference

12 December 2020

Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists

1 reference

12 December 2020

Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin

1 reference

12 December 2020

The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B

1 reference

12 December 2020

Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily

1 reference

12 December 2020

Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.

1 reference

12 December 2020

The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system

1 reference

12 December 2020

Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture

1 reference

12 December 2020

Administration of melatonin to non-human primates and to women with breast carcinoma

1 reference

12 December 2020

Is cytoskeletal tension a major determinant of cell deformability in adherent endothelial cells?

1 reference

12 December 2020

Night shiftwork and breast cancer risk: overall evidence

1 reference

12 December 2020

Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells

1 reference

12 December 2020

The loss of mdm2 induces p53-mediated apoptosis

1 reference

12 December 2020

Melatonin effects on intercellular junctional communication in MCF-7 human breast cancer cells

1 reference

12 December 2020

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response

1 reference

12 December 2020

Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis

1 reference

12 December 2020

Preventive effects of raloxifene and melatonin in N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats.

1 reference

12 December 2020

Plasma melatonin in patients with breast cancer

1 reference

12 December 2020

Clinical study of melatonin in untreatable advanced cancer patients

1 reference

12 December 2020

Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells

1 reference

12 December 2020

Developmental expression of 'RZR beta, a putative nuclear-melatonin receptor' mRNA in the suprachiasmatic nucleus of the rat

1 reference

12 December 2020

Melatonin and vitamin D3 synergistically down‐regulate Akt and MDM2 leading to TGFβ‐1‐dependent growth inhibition of breast cancer cells

1 reference

12 December 2020

Inverse correlation between the metastatic capacity of cell clones derived from a rat mammary carcinoma and their intercellular communication with normal fibroblasts.

1 reference

12 December 2020

Oncostatic action of melatonin: facts and question marks

1 reference

12 December 2020

Melatonin regulates the mRNA expression of the mt(1) melatonin receptor in the rat Pars tuberalis

1 reference

12 December 2020

Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization.

1 reference

12 December 2020

Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway

1 reference

12 December 2020

Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.

1 reference

12 December 2020

Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate

1 reference

12 December 2020

Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro

1 reference

12 December 2020

Perspectives in Pineal Functions

1 reference

12 December 2020

Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro

1 reference

12 December 2020

Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro

1 reference

12 December 2020

Reactive Oxygen Species and Antioxidants in Signal Transduction and Gene Expression

1 reference

12 December 2020

Implications for interrelationships between nuclear architecture and control of gene expression under microgravity conditions

1 reference

12 December 2020

Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7.

1 reference

12 December 2020

Medical implications of melatonin: receptor-mediated and receptor-independent actions

1 reference

12 December 2020

Endocrine and immune effects of melatonin therapy in metastatic cancer patients

1 reference

12 December 2020

Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells

1 reference

12 December 2020

Lifestyle and breast cancer recurrences: the DIANA-5 trial

1 reference

12 December 2020

Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions

1 reference

12 December 2020

Melatonin in clinical oncology.

1 reference

12 December 2020

Direct action of melatonin in human granulosa-luteal cells

1 reference

12 December 2020

Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes

1 reference

12 December 2020

Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities

1 reference

12 December 2020

Effects of melatonin on microtubule assembly depend on hormone concentration: Role of melatonin as a calmodulin antagonist

1 reference

12 December 2020

The coregulator exchange in transcriptional functions of nuclear receptors

1 reference

12 December 2020

Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen

1 reference

12 December 2020

Melatonin modulates growth factor activity in MCF-7 human breast cancer cells

1 reference

12 December 2020

Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells

1 reference

12 December 2020

Luzindole (N-0774): a novel melatonin receptor antagonist.

1 reference

12 December 2020

Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity

1 reference

12 December 2020

Molecular signaling regulating anchorage-independent growth of cancer cells.

1 reference

12 December 2020

In vitro inhibition of Ca2+/calmodulin-dependent kinase II activity by melatonin

1 reference

12 December 2020

Gene expression in space

1 reference

12 December 2020

10.1007/S00018-012-1161-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007844%20AND%20SRC:MED&resulttype=core&format=json